Back to User profile » Dr Long-kuan Xu
Paper published by Dr Long-kuan Xu:
Original Research
Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
Jin M, Jiang ZQ, Qin JH, Qin HX, Jiang KW, Ya HX, Gu J, Gui MR, Li YH, Xu LK, Fu HX, Xiao XH, Li SQ
Journal of Hepatocellular Carcinoma 2024, 11:2309-2320
Published Date: 25 November 2024